Comparing treatment and outcomes in advanced esophageal, gastroesophageal junction, and gastric adenocarcinomas: a population-based study.
Marieke PapePauline A J VissersWillemieke P M DijksterhuisDavid BertwistleLaura McDonaldBianca MostertSarah DerksIrma M OvingRob H A VerhoevenHanneke W M van LaarhovenPublished in: Therapeutic advances in medical oncology (2023)
Despite differences in clinical characteristics and treatment strategies, survival between patients with advanced EAC, GEJC, and GAC was similar. We advocate that EAC patients should not be excluded from clinical trials for patients with molecularly similar GEJC/GAC.